CLINICAL TRIALS AND OBSERVATIONS Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma

نویسندگان

  • Heinz Ludwig
  • Roman Hajek
  • Elena Tóthová
  • Johannes Drach
  • Zdenek Adam
  • Boris Labar
  • Miklós Egyed
  • Ivan Spicka
  • Heinz Gisslinger
  • Richard Greil
  • Ingrid Kuhn
  • Niklas Zojer
  • Axel Hinke
چکیده

1Department of Medicine I, Wilhelminenspital Vienna, Vienna, Austria; 2Internal Hematooncological Clinic, Faculty Hospital Brno and Faculty of Medicine MU, Brno, Czech Republic; 3Clinic of Hematology, Faculty Hospital with Policlinic, Kosice, Slovakia; 4Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria; 5Clinical Hospital “Rebro,” Zagreb, Croatia; 6Department of Internal Medicine, Kaposi Mór Teaching Hospital, Kaposvár, Hungary; 7First Internal Clinic, Charles University, Prague, Czech Republic; 8Department of Hematology, University Clinic, Vienna, Austria; 9University Clinic, Salzburg, Austria; 10Schering-Plough AESCA Pharma, Traiskirchen, Austria; and 11Wissenschaftlicher Service Pharma Research Institute, Langenfeld, Germany

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

CLINICAL TRIALS AND OBSERVATIONS High incidence of arterial thrombosis in young patients treated for multiple myeloma: results of a prospective cohort study

This prospective study evaluated the risk of arterial thrombosis in 195 consecutive patients aged 18 to 65 years with newly diagnosed multiple myeloma (MM). All patients were treated with 3 cycles of VAD (vincristine, doxorubicin, and dexamethasone) or TAD (thalidomide-AD) or PAD (bortezomib-AD) in national trials, followed by high-dose melphalan and autologous stem cell transplantation. For a ...

متن کامل

CLINICAL TRIALS AND OBSERVATIONS Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure

1Department of Lymphoma and Myeloma, M. D. Anderson Cancer Center, Houston, TX; 2Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece; 3Department of Medicine, Princess Margaret Hospital, Toronto, ON; 4Hematology Department, Institute of Hematology and Oncology, Hospital Clinic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universit...

متن کامل

CLINICAL TRIALS AND OBSERVATIONS Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

Anders Waage,1 Peter Gimsing,2 Peter Fayers,1,3 Niels Abildgaard,4 Lucia Ahlberg,5 Bo Björkstrand,6 Kristina Carlson,7 Inger Marie Dahl,8 Karin Forsberg,9 Nina Gulbrandsen,10 Einar Haukås,11 Øyvind Hjertner,1 Martin Hjorth,12 Torbjörn Karlsson,13 Lene Meldgaard Knudsen,14 Johan Lanng Nielsen,15 Olle Linder,16 Ulf-Henrik Mellqvist,17 Ingerid Nesthus,18 Jürgen Rolke,19 Maria Strandberg,20 Jon Hja...

متن کامل

CLINICAL TRIALS AND OBSERVATIONS Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan- prednisone (VMP) in untreated multiple myeloma patients with renal impairment

Fortunato Morabito,1 Massimo Gentile,1 Carla Mazzone,1 Davide Rossi,2 Francesco Di Raimondo,3 Sara Bringhen,4 Roberto Ria,5 Massimo Offidani,6 Francesca Patriarca,7 Chiara Nozzoli,8 Maria Teresa Petrucci,9 Giulia Benevolo,10 Iolanda Vincelli,11 Tommasina Guglielmelli,12 Mariella Grasso,13 Roberto Marasca,14 Luca Baldini,15 Vittorio Montefusco,16 Pellegrino Musto,17 Nicola Cascavilla,18 Ignazio ...

متن کامل

CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Superiority of thalidomide and dexamethasone over vincristine-doxorubicin- dexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma

The aim of the present study was to compare thalidomide-dexamethasone (Thal-Dex) and vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous peripheral blood stem-cell (PBSC) transplantation for multiple myeloma (MM). For this purpose, we performed a retrospective matched case-control analysis of 200 patients who entered 2 consecutive studies from 1996 to 200...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2009